Mengxing Wu
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Development of a Prediction Model for Progression Risk in High-Grade Gliomas Based on Habitat Radiomics and Pathomics.
Journal: Annals of clinical and translational neurology
Published: August 14, 2025
Radiomic analysis based on machine learning of multi-sequences MR to assess early treatment response in locally advanced nasopharyngeal carcinoma.
Journal: Science progress
Published: May 08, 2025
Deep learning and pathomics analyses predict prognosis of high-grade gliomas.
Journal: Frontiers in neurology
Published: April 19, 2025
Efficacy, safety and cost-effectiveness of chemo-immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: an updated systematic review and cost-effectiveness analysis.
Journal: Translational cancer research
Published: February 23, 2025
A prognostic model for head and neck squamous cell carcinoma based on radiotherapy sensitivity insights from nasopharyngeal carcinoma.
Journal: Discover oncology
Published: October 23, 2024
A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 22, 2024
Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
Journal: Oral oncology
Published: March 15, 2024
Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.
Journal: BMC cancer
Published: January 11, 2024
A MRI-based radiomics model for predicting the response to anlotinb combined with temozolomide in recurrent malignant glioma patients.
Journal: Discover oncology
Published: March 24, 2023
MRI-based clinical radiomics nomogram may predict the early response after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Journal: Frontiers in oncology
Published: March 24, 2023
Last Updated: 09/26/2026